14.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.68
Aprire:
$13.84
Volume 24 ore:
1.44M
Relative Volume:
1.16
Capitalizzazione di mercato:
$1.16B
Reddito:
$1.53B
Utile/perdita netta:
$40.23M
Rapporto P/E:
29.72
EPS:
0.5
Flusso di cassa netto:
$60.93M
1 W Prestazione:
+4.72%
1M Prestazione:
+23.32%
6M Prestazione:
-29.67%
1 anno Prestazione:
-27.05%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Confronta IART con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IART
Integra Lifesciences Holdings Corp
|
14.86 | 1.09B | 1.53B | 40.23M | 60.93M | 0.50 |
![]()
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-31 | Aggiornamento | Argus | Hold → Buy |
2024-12-02 | Iniziato | Morgan Stanley | Underweight |
2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-11-14 | Iniziato | CL King | Buy |
2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
2023-06-08 | Downgrade | Argus | Buy → Hold |
2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
2022-04-13 | Downgrade | Truist | Buy → Hold |
2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
2020-05-27 | Iniziato | Citigroup | Neutral |
2020-04-03 | Iniziato | SunTrust | Buy |
2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
2019-01-03 | Iniziato | SunTrust | Buy |
2018-11-28 | Iniziato | UBS | Neutral |
2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
Will a bounce in Integra LifeSciences Holdings Corporation offer an exitMarket Performance Summary & Verified Technical Signals - Newser
Can machine learning forecast Integra LifeSciences Holdings Corporation recoveryLong Setup & Weekly Top Gainers Alerts - Newser
Unpacking the Artificial Skin Substitute Market's Evolution, - openPR.com
Cerebral Spinal Fluid Management Device Market Insights & - openPR.com
Technical analysis overview for Integra LifeSciences Holdings Corporation stockPortfolio Value Report & Free Safe Entry Trade Signal Reports - Newser
Candlestick signals on Integra LifeSciences Holdings Corporation stock todayJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Improved Revenues Required Before Integra LifeSciences Holdings Corporation (NASDAQ:IART) Stock's 27% Jump Looks Justified - 富途牛牛
Smart tools for monitoring Integra LifeSciences Holdings Corporation’s price action2025 Institutional Moves & Growth Focused Entry Point Reports - Newser
Is Integra LifeSciences Holdings Corporation trending in predictive chart modelsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Visual analytics tools that track Integra LifeSciences Holdings Corporation performance2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Using data models to predict Integra LifeSciences Holdings Corporation stock movementEarnings Overview Summary & Fast Momentum Stock Entry Tips - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationPortfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explainedQuarterly Portfolio Review & Long-Term Safe Investment Plans - Newser
Top chart patterns to watch in Integra LifeSciences Holdings CorporationMarket Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Applying chart zones and confluence areas to Integra LifeSciences Holdings Corporation2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationCEO Change & Fast Momentum Entry Tips - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisJuly 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Applying sector rotation models to Integra LifeSciences Holdings Corporation2025 Analyst Calls & Entry Point Strategy Guides - Newser
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser
Relative strength of Integra LifeSciences Holdings Corporation in sector analysis2025 Price Momentum & Daily Market Momentum Tracking - Newser
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - Yahoo Finance
IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook - Yahoo Finance
Developing predictive dashboards with Integra LifeSciences Holdings Corporation dataCEO Change & Free Community Consensus Stock Picks - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stock [Quarterly Growth Report]Free Weekly High Potential Stock Alerts - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionBuy Zone Strategy with Pattern Recognition - Newser
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation stock daily chart insightsConsistent Profit Signals with AI Models - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Integra Lifesciences (IART.O) Plunges 6.3% — What’s Behind the Sudden Drop? - AInvest
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Integra Lifesciences Holdings Corp Azioni (IART) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):